🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07542392
Recruiting Not applicable

Effects of Midwife-guided biırth Affirmation Cards on Labor Process and Experience ın Primigravidas

NCT07542392 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-03-27
Last updated
2026-05-19

Condition(s) studied

Duration of LaborLabor PainFear of ChildbirthControl (Internet Only)Support

Investigational drug(s) / intervention(s)

Midwife-Guided Birth Affirmation Cards

Midwife-Guided Birth Affirmation Cards: The intervention consists of the application of structured affirmation (positive statement) cards integrated into standard midwifery care during the active phase of labor. A standardized set of 24 culturally appropriate affirmation cards, developed based on literature and expert opinion, will be used. Each participant in the intervention group will be invited to select or be guided to use a subset of these cards (e.g., 4-6 cards) according to personal preference. During uterine contractions, participants will be encouraged to focus on the selected affirmation statements and repeat them silently or aloud in synchronization with breathing techniques. The midwife will support the process by presenting the cards in a visible area, reading them aloud when needed, and providing verbal encouragement. The intervention will be applied in short cycles (approximately 10-15 minutes) depending on the participant's tolerance and can be repeated throughout the active phase of labor.

Study summary

The aim of this study is to evaluate the effects of midwife-guided birth affirmation cards on labor duration, pain level, fear of childbirth, perceived control, and perceived support in primigravidas. The study seeks to determine whether this non-pharmacological approach used during labor improves the childbirth experience. Accordingly, the research aims to answer the question: "Do midwife-guided birth affirmation cards affect labor duration and the childbirth experience, including pain, fear, perceived control, and perceived support, in primigravidas?"

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Having a singleton pregnancy between 37-42 weeks of gestation * Being between 18-40 years of age * Being a primigravida * Having a cephalic presentation with vertex position * Being in the active phase of labor (cervical dilatation ≥4 cm) * Accepting non-invasive interventions * Having no mental or physical disability * Being able to understand and speak Turkish * Willingness to participate in the study Exclusion Criteria: * High-risk pregnancies * Pregnant women at risk of intrapartum complications (e.g., oligohydramnios, polyhydramnios, intrauterine fetal demise, placenta previa, placental abruption, acute fetal distress, preeclampsia, fetal dystocia, macrosomia, etc.) * Pregnant women with a history of medical or obstetric complications * Women who have attended antenatal education classes (pregnancy school) * Women using epidural analgesia or other pharmacological pain management methods * Women experiencing communication difficulties * Women who are unwilling to participate in the study Exclusion Criteria from the Study * Experiencing dizziness, shortness of breath, or other discomfort, * Difficult and prolonged labor, instrumental delivery, placental retention, postpartum hemorrhage, need for neonatal intensive care, * Situations requiring emergency cesarean section during labor, * The woman will be excluded from the study if she ceases to cooperate during labor.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mut Devlet Hastanesi Mut Mersi̇n Recruiting

More KTO Karatay University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07542392 on ClinicalTrials.gov ↗ ← All trials in Turkey